| Vey, Norbert |
| Recruiting | 3 | 124 | Europe | EPREX, Epoetin alfa | Groupe Francophone des Myelodysplasies | Myelodysplastic Syndromes | 05/22 | 05/24 | | |
| Recruiting | 3 | 322 | Europe, Canada, US | Crenolanib, Crenolanib besylate, Cytarabine, Mitoxantrone, Placebo Oral Tablet, Fludarabine, Idarubicin, G-CSF | Arog Pharmaceuticals, Inc. | Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations | 10/24 | 10/24 | | |
| Recruiting | 3 | 142 | Europe | Dexamethasone, Amsacrine, Cytarabine, Azacitidine | University Hospital, Toulouse | Relapsed or Refractory Acute Myeloid Leukemia | 12/25 | 12/25 | | |
BIG-1, NCT02416388: Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR |
|
|
| Recruiting | 2/3 | 3100 | Europe | Idarubicin, Daunorubicin, HD Cytarabine, Cyclosporine, Methotrexate, Mycophenolic acid (MPA), vosaroxin, ID cytarabine, Dexamethasone, Venetoclax | University Hospital, Angers | Acute Myeloid Leukemia (AML) | 07/25 | 01/32 | | |
| Active, not recruiting | 2 | 68 | Europe | AG-221, Enasidenib | Groupe Francophone des Myelodysplasies | Myelodysplastic Syndromes, Leukemia Acute Myeloid | 02/23 | 03/26 | | |
| Active, not recruiting | 2 | 68 | Europe | AG-120 | Groupe Francophone des Myelodysplasies | Myelodysplastic Syndromes, Acute Myeloid Leukemia | 04/25 | 04/25 | | |
AVENHIR, NCT05768711: Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia |
|
|
| Recruiting | 2 | 44 | Europe | Venetoclax, ABT-199 | Groupe Francophone des Myelodysplasies, AbbVie | Chronic Myeloid Leukemia | 02/26 | 10/28 | | |
| Recruiting | 1/2 | 150 | Europe, US | IV ICT01 | ImCheck Therapeutics, ImCheck Therapeutics, Inc. | Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer | 06/25 | 12/25 | | |
|
| Recruiting | 1/2 | 78 | Europe, US | AB8939, Azacitidine | AB Science, AB Science | Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia | 12/24 | 12/24 | | |
NCT05782127: Oral Azacitidine Combined with Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes |
|
|
| Recruiting | 1/2 | 36 | Europe | Onureg + Venetoclax, CC-486 + ABT-199 | Groupe Francophone des Myelodysplasies, Bristol-Myers Squibb, AbbVie | Untreated Myelodysplastic Syndrome | 11/25 | 11/28 | | |
NCT05181735: Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA |
|
|
| Recruiting | 1/2 | 150 | Europe | Luspatercept Injection [Reblozyl], ACE-536, Eprex, Epoietin alfa | Groupe Francophone des Myelodysplasies, Celgene | MDS, Myelodysplastic Syndromes | 05/27 | 11/27 | | |
INA03, NCT03957915: Study of Escalating Doses of Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia |
|
|
| Active, not recruiting | 1 | 33 | Europe | INA03 administration | Institut Paoli-Calmettes, INATHERYS | Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukaemia Recurrent, Mixed Phenotype Acute Leukemia | 07/24 | 07/25 | | |
HEMATO-BIO, NCT02320656: Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders--IPC-2013-015 |
|
|
| Recruiting | N/A | 650 | Europe | Blood sampling, Bone marrow aspirate, Skin biopsy, Buccal swab | Institut Paoli-Calmettes | Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders | 05/19 | 05/24 | | |
NCT02938858: French Registry of First-line Treatment of Acute Promyelocytic Leukemia |
|
|
| Recruiting | N/A | 400 | Europe | | Groupe Francophone des Myelodysplasies, Teva Pharmaceuticals USA | Acute Promyelocytic Leukemia | 10/20 | 10/22 | | |
NCT03275480: Institut Paoli Calmettes Myelodysplastic Syndromes Database |
|
|
| Recruiting | N/A | 10000 | Europe | | Institut Paoli-Calmettes | Myelodysplastic Syndromes | 01/30 | 12/30 | | |
| Castillo, Laura |
crossed1, NCT05810129: Crossed Education in Relation to Muscle Mass in Patients Operated of Clavicular Fracture |
|
|
| Recruiting | N/A | 39 | RoW | concentric-eccentric strength training, eccentric strength training, standard physical therapy | Universidad de La Frontera | Clavicle Fracture | 07/24 | 10/24 | | |
